Financial & Business News
LATEST INVESTING HEADLINES
SHANGHAI, China, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Hesai Group (NASDAQ: HSAI) (“Hesai” or the “Company”), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced the launch of its global offering (the “Global Offering”) of 17,000,000 Class B ordinary shares of the Company, which comprises a Hong Kong public offering of initially 1,700,000 Class B ordinary shares commencing on September 8, 2025 Hong Kong time (the “Hong Kong Public Offering”) and an international offering of initially 15,300,000 Class B ordinary shares commencing today (the “International Offering”), and dual-primary listing of its Class B ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) under the stock code “2525”.
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Air Lease Corporation (NYSE: AL)'s sale to Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield for $65.00 per share in cash.
VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that further to the press release dated August 22, 2025, the holders (the "Holders") of convertible debentures in the principal amount of $710,000 (the "Debentures") have entered into amending agreements to amend the terms of the Debentures of the company issued on September 7, 2022.
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for VONVENDI® [von Willebrand factor (Recombinant)], expanding the indication to include routine prophylaxis to reduce the frequency of bleeding episodes in adults with von Willebrand Disease (VWD), including those with Type 1 and 2 disease, and on-demand and perioperative management of bl.
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR).
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd.
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Quantum Corporation (NASDAQ: QMCO) securities between November 15, 2024 and August 18, 2025.
Supply is outstripping demand, and traders are betting on a fall. What's keeping prices up?
U.S. LNG firm New Fortress Energy posted a wider second-quarter loss on Friday, as lower contributions due to asset sales weighed on its performance.
Vancouver, B.C. – TheNewswire - September 5, 2025 ‐ Armory Mining Corp. (CSE: ARMY) (OTC: RMRYF) (FRA: 2JS) (the “Company”) is pleased to announce that it has closed the second and final tranche (the “Final Tranche”) of its oversubscribed non-brokered private placement offering (the “Offering”), previously announced by the Company on August 25, 2025 and August 7, 2025. Under the Final Tranche, the Company issued an additional 1,000,000 units (the “Units”) at a price of $0.05 per Unit for gross proceeds of $50,000. Each Unit is comprised of one common share and one transferrable common share purchase warrant (a “Warrant”). Each Warrant issued under the Final Tranche entitles the holder to acquire an additional common share at a price of $0.065 per common share until September 5, 2028.